A recent study published in the journal Molecular Psychiatry provides evidence that a combination of non-invasive brain scanning and computer modeling can successfully measure how a dementia drug ...

Patients with obesity sometimes have leptin resistance, and the "full" feeling does not get through to the brain. The new ...

A powerful editorial published today in Brain Medicine raises alarm about a previously overlooked threat to brain development and public health: the disruption of sterol biosynthesis by common ...

Targeted modulation of certain intracellular signaling proteins could represent an exciting new approach to drug development.

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain has developed a drug candidate that could help fight the condition at its ...

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...

Researchers create the first sex-specific GLP-1 brain atlas, revealing why weight-loss drugs work differently in men and women.

Explore the promising early results of PRI-101, a new treatment for Parkinson's disease aimed at targeting neurodegeneration.

Months after promising help for “hundreds of thousands of kids,” the FDA approved the decades-old medicine for a disease ...